ETrade Capital Management’s Elevance Health ELV Stock Holding History

ETrade Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.25M	Sell	4,634 -252	-5%	-$67.8K	0.02%	318
2020 Q2	$1.28M	Sell	4,886 -233	-5%	-$62.2K	0.03%	287
2020 Q1	$1.16M	Sell	5,119 -457	-8%	-$125K	0.03%	269
2019 Q4	$1.68M	Sell	5,576 -598	-10%	-$165K	0.04%	243
2019 Q3	$1.48M	Buy	6,174 +320	+5%	+$87.7K	0.04%	256
2019 Q2	$1.65M	Buy	5,854 +808	+16%	+$221K	0.04%	243
2019 Q1	$1.45M	Sell	5,046 -785	-13%	-$227K	0.04%	248
2018 Q4	$1.53M	Sell	5,831 -1,367	-19%	-$376K	0.05%	213
2018 Q3	$1.97M	Buy	7,198 +793	+12%	+$206K	0.06%	202
2018 Q2	$1.52M	Buy	6,405 +630	+11%	+$146K	0.05%	231
2018 Q1	$1.27M	Sell	5,775 -211	-4%	-$49.6K	0.04%	267
2017 Q4	$1.35M	Buy	5,986 +265	+5%	+$56.4K	0.04%	275
2017 Q3	$1.09M	Buy	5,721 +847	+17%	+$161K	0.04%	310
2017 Q2	$917K	Buy	4,874 +1,142	+31%	+$205K	0.04%	292
2017 Q1	$617K	Buy	3,732 +1,911	+105%	+$304K	0.03%	394
2016 Q4	$262K	Buy	+1,821	New	+$244K	0.01%	504
2014 Q2	–	Sell	-284	Closed	-$28K	–	519
2014 Q1	$28K	Buy	284 +14	+5%	+$1.27K	﹤0.01%	619
2013 Q4	$25K	Sell	270 -22	-8%	-$1.96K	﹤0.01%	562
2013 Q3	$24K	Buy	292 +93	+47%	+$7.97K	﹤0.01%	528
2013 Q2	$16K	Buy	+199	New	+$14.9K	﹤0.01%	523

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ETrade Capital Management's ELV Position: Q3 2020 in Review

ETrade Capital Management reduced its Elevance Health (ELV) stake by 5.2% in Q3 2020, selling an estimated $67.8K and leaving 4,634 shares worth $1.25M. The position accounts for 0.02% of the portfolio, ranked #318.

ETrade Capital Management first reported a position in ELV in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.97M in Q3 2018. 1,095 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

ETrade Capital Management held 4,634 shares of Elevance Health worth $1.25M as of Q3 2020.
ETrade Capital Management sold 252 Elevance Health shares in Q3 2020, an estimated $67.8K.
Elevance Health made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #318 holding.
ETrade Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 20 quarters since.
ETrade Capital Management's Elevance Health position peaked at $1.97M in Q3 2018.
1,095 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.